BURU.AMEXNuburu, INC

S-1: NUBURU Files S-1 for 130M Share Resale Amid Strategic Pivot

Sentiment:

Registration Statement


NUBURU, Inc. filed an S-1 registration statement for the resale of up to 130 million common shares by a selling stockholder, aiming to fund its Transformation Plan and recent strategic acquisitions despite ongoing financial losses and NYSE non-compliance.

Delay expectedThe Tekne acquisition has faced delays due to feedback from the Italian government's Golden Power review, leading to modified terms and a new Golden Power application submission by December 31, 2025.The original Trumar Agreement for the TCEI Acquisition (including Tekne and Orbit) expired on July 31, 2025, because certain conditions were not satisfied, necessitating new agreements and further approvals.The Orbit Acquisition's final tranche closing is scheduled for no later than December 31, 2026, and requires stockholder approval for preferred stock issuance and NYSE American approval of certain terms, introducing potential for further delays.The Lyocon acquisition is scheduled to close by December 31, 2025, but is subject to due diligence and customary closing conditions, which could cause delays.The formation of the Maddox JV has a target definitive agreement execution date of December 15, 2025, which is a tight timeline and could be subject to delays.
Capital raiseEntered into a Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD. for up to $100 million in common stock sales, with $21.9 million already received in net cash proceeds through December 8, 2025.Completed a best efforts public offering on September 16, 2025, raising $10.7 million in net cash proceeds through the issuance of common stock and warrants.Entered into various convertible note agreements in 2025 with parties like Indigo Capital LP, 1800 Diagonal Lending LLC, Boot Capital LLC, Brick Lane Capital Management Limited, and Bomore Opportunity Group Ltd, providing capital infusions and debt exchanges.Entered into a convertible facility with Supply@ME Capital Plc (SYME) to loan up to $5.15 million, which is expected to convert into a controlling interest in SYME.Intends to provide EUR 15 million in support to Tekne, including a EUR 13 million convertible loan, conditioned on acquiring an initial 2.9% interest and Italian government approval.Nuburu Defense plans to contribute up to $10 million in funding to the Maddox JV.
Worse than expectedReported significant net losses of $34.5 million in 2024 and $51.3 million for the nine months ended September 30, 2025, indicating a worsening financial performance compared to prior periods.Accumulated deficit increased to $172.7 million as of September 30, 2025, highlighting continued unprofitability.Revenue declined drastically from $2.08 million in 2023 to $152,127 in 2024, and was nil for the first nine months of 2025, reflecting a severe downturn in core business operations.Received a Notice of Noncompliance from NYSE American due to insufficient stockholders' equity, indicating a precarious financial position.Incurred a $1.0 million loss from a fraudulent wire transfer, representing a direct financial hit.Experienced a $6.06 million impairment loss on inventories, property, and equipment due to lease default and asset disposal, reflecting significant operational setbacks.

Summary

  • NUBURU, Inc. (the Company) is registering up to 130 million shares of common stock for resale by YA II PN, LTD. (the Selling Stockholder) under a Standby Equity Purchase Agreement (SEPA).
  • The Company will not receive proceeds from the Selling Stockholder's resale, but may receive up to $28.5 million from direct sales to the Selling Stockholder based on the December 8, 2025 closing price of $0.2262 per share.
  • The SEPA allows the Company to sell up to $100 million of common stock to the Selling Stockholder over 36 months, with sales at the Company's discretion and a purchase price at a 3% discount to the lowest daily VWAP over a three-day period.
  • The Company has already issued 50 million shares to the Selling Stockholder under the SEPA, including 2,665,246 commitment shares as fees, generating $21,909,405 in net cash proceeds through December 8, 2025.
  • NUBURU reported a net loss of $34,515,754 for the year ended December 31, 2024, and $51,257,996 for the nine months ended September 30, 2025.
  • The accumulated deficit reached $172,666,551 as of September 30, 2025.
  • The Company is implementing a 'Transformation Plan' focused on diversifying its asset base through strategic acquisitions and investments in defense-tech, security, and operational resilience solutions.
  • Key acquisitions include planned controlling interests in Tekne S.p.A. (defense-tech), Supply@ME Capital Plc (fintech/inventory monetization), Orbit S.r.l. (operational resilience software), and Lyocon S.r.l. (laser-engineering and photonics).
  • The Company received a Notice of Noncompliance from NYSE American on April 29, 2025, for failing to maintain stockholders' equity of $2.0 million, and has until October 29, 2026, to regain compliance.
  • NUBURU's patent portfolio was foreclosed upon by senior secured lenders in March 2025, extinguishing $8,961,872 of junior and senior secured notes, while the Company retained non-patent intellectual property.
  • A fraudulent wire transfer in October 2025 resulted in a loss of $1,005,352, which the Company does not expect to recover.
  • The Company completed a public offering on September 16, 2025, raising $11,994,884 in gross proceeds ($10,744,346 net) through the sale of common stock and warrants.
  • The Company is obligated to redeem its Series A Preferred Stock for $10.00 per share ($23,889,050 total) as of January 31, 2025, but currently lacks legally available funds.
  • The Company incurred a loss on impairment of inventories, property, and equipment, and operating lease right-of-use asset totaling $6,064,823 in the nine months ended September 30, 2025, due to a lease default and landlord actions.

Sentiment

Score: 3

Explanation: The company is in a highly precarious financial position with recurring significant losses, a substantial accumulated deficit, and a 'going concern' qualification from auditors. NYSE non-compliance and the loss of its patent portfolio are major setbacks. While the 'Transformation Plan' and multiple capital-raising efforts (SEPA, public offering, convertible notes) indicate active efforts to pivot and secure funding, the execution risks for these acquisitions are high, and the company's ability to achieve profitability remains uncertain. The fraudulent wire transfer further highlights operational vulnerabilities. The overall sentiment is negative due to severe financial distress, despite strategic initiatives.

Positives

  • Secured a Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD. for up to $100 million, providing a potential source of capital.
  • Successfully extinguished all long-term, secured indebtedness through a combination of debt conversion and the foreclosure sale of its patent portfolio, reducing its debt burden.
  • Actively pursuing a 'Transformation Plan' to diversify its business into defense-tech, security, and operational resilience solutions through strategic acquisitions.
  • Completed a public offering on September 16, 2025, raising $10,744,346 in net cash proceeds.
  • Received NYSE American acceptance of its Compliance Plan to regain listing standards, with a plan period until October 29, 2026.

Negatives

  • Experienced significant net losses of $34,515,754 in 2024 and $51,257,996 for the nine months ended September 30, 2025.
  • Accumulated deficit has grown to $172,666,551 as of September 30, 2025, raising substantial doubt about its ability to continue as a going concern.
  • Received a Notice of Noncompliance from NYSE American for failing to meet stockholders' equity requirements, indicating financial distress.
  • Lost its patent portfolio through a foreclosure sale by senior secured lenders in March 2025, significantly impacting its original blue laser technology business model.
  • Incurred a $1,005,352 loss due to email fraud in October 2025, with no expectation of recovery.
  • Discontinued manufacturing operations and wrote down inventory, property, and equipment to zero due to lease default and landlord actions, resulting in a $6,064,823 impairment loss.
  • Revenue decreased significantly to $152,127 in 2024 from $2,085,532 in 2023, and was nil for the nine months ended September 30, 2025, and 2024.
  • Obligated to redeem Series A Preferred Stock for $23,889,050 as of January 31, 2025, but lacks legally available funds for redemption.
  • Experienced employee furloughs and resignations due to lack of funding, impacting operations and business plan execution.

Risks

  • Inability to predict the actual number of shares sold under the SEPA or the actual gross proceeds, leading to potential investor dilution.
  • Future resales and/or issuances of common stock, including under the SEPA, may cause the market price to drop significantly and dilute stockholders.
  • Proceeds from SEPA sales may be used in ways that do not yield significant returns or with which investors may disagree.
  • No guarantee that planned acquisitions of interests in Tekne, SYME, Orbit, or Lyocon will close.
  • Monetary contributions made to targeted investment entities for planned acquisitions may be unrecoverable if deals do not close.
  • Strategic transactions involve numerous risks, including competition, integration difficulties, diversion of management attention, and assumption of unknown liabilities.
  • An investment in common stock carries a high degree of risk, with no certainty of return, and stockholders may not be adequately compensated for business and financial risks.
  • Difficulty managing growth in business, which could adversely affect financial condition and results of operations.
  • Products and services involve lengthy sales and installation cycles, potentially leading to significant expenses without offsetting revenues.
  • Failure to meet customer price expectations could negatively impact demand for products.
  • Dependence on government entities for revenue exposes the Company to risks from changes in contracting or fiscal policies.
  • High dependence on key executives and ability to attract and retain qualified personnel.
  • Expectations and targets for product launches depend on assumptions and estimates that, if incorrect, could materially affect operating results.
  • Significant research and development expenses for new products could increase losses and negatively impact profitability.
  • Insurance coverage may not adequately protect against harm or losses.
  • No assurance of successful execution of the business model, making investment highly speculative.
  • International expansion subjects the Company to various risks and uncertainties, including compliance with foreign laws, currency fluctuations, and intellectual property enforcement challenges.
  • Hesitancy of potential customers to adopt novel technologies or switch from existing ones.
  • Rapid technological changes in the market demand significant R&D investment, and failure to address changes could harm the business.
  • Litigation, regulatory actions, and compliance issues could lead to significant fines, penalties, and negative publicity.
  • Laws and regulations related to privacy, information security, and data protection could increase costs and adversely affect business opportunities.
  • Exposure to various export controls, tariffs, and trade and economic sanctions laws and regulations.
  • Liability for environmental damages from operations could negatively impact reputation and operating results.
  • Inability to protect, defend, maintain, or enforce intellectual property rights, leading to competitors offering similar products.
  • Subject to third-party claims of infringement, misappropriation, or other intellectual property violations.
  • Inability to protect intellectual property rights globally.
  • Claims of misappropriation of third-party intellectual property or breach of non-competition/non-solicitation agreements by employees.
  • Cyber-attacks and other disruptions, security breaches, and incidents could harm business and reputation.
  • Natural disasters, unusual weather, epidemics, terrorist acts, and political events could disrupt business.
  • NYSE American may delist securities from trading, limiting investor transactions and subjecting the Company to additional trading restrictions.
  • Material weaknesses in internal control over financial reporting, leading to potential inaccurate financial reporting and adverse investor confidence.
  • Management has limited experience operating a public company.
  • Redemption of Preferred Stock may require significant cash and result in adverse tax consequences.
  • Outstanding convertible notes, preferred stock, and warrants contain anti-dilution protection, potentially causing significant dilution to stockholders.
  • Public Warrants may be redeemed prior to exercise at a disadvantageous time, making them worthless.
  • Common Stock is subordinated to Preferred Stock.

Future Outlook

The Company plans to continue its 'Transformation Plan' by aggressively pursuing strategic acquisitions and investments in defense-tech, security, and operational resilience solutions. It expects to incur significant expenses and operating losses for the foreseeable future until full commercialization is achieved, relying on proceeds from equity and debt financings, including the SEPA. Future research and development will focus on strategic licensing and applications in the defense industry, with outsourced manufacturing and inventory management. The Company intends to regain NYSE American compliance through these transactions and is actively seeking a new, more appropriate leased facility.

Management Comments

  • Management is aggressively pursuing its growth strategy through a series of acquisitions, investments and procurement arrangements.
  • We believe that having access to strategic transactions sourced by our executives is critical to our future success and anticipate similar transactions in the future.
  • We are adjusting our laser business to focus on licensing and joint development within specific verticals, as well as outsourced production.
  • We believe that, upon consummation of certain of the transactions that we have recently announced, we will be able to regain compliance with NYSE American listing standards.

Industry Context

NUBURU is pivoting from its historical focus on high-power blue industrial lasers, a market characterized by rapid technological change and intense competition from established players like Coherent, nLight, and IPG Photonics, as well as emerging green laser technologies. The Company's new 'Transformation Plan' aims to diversify into defense-tech, security, and operational resilience solutions, and inventory monetization platforms. This shift aligns with broader trends of companies seeking synergies across diverse technology sectors and leveraging fintech for working capital solutions. The defense sector offers potential for government contracts, while operational resilience software addresses critical needs for mission-critical corporations. The inventory monetization platform (SYME) taps into a growing demand for non-credit, non-debt financing solutions for manufacturing and trading companies.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Executive Chairman and Co-Chief Executive OfficerRon Nicol (former Executive Chairman), Brian Knaley (former CEO)Alessandro Zamboni2025-01-13Appointment in connection with the Transformation Plan.
Co-Chief Executive Officer and Chief Executive Officer of NUBURU DefenseNADario Barisoni2025-10-01Appointment to lead diversification strategy, ceased to be an independent director.
Chief Executive Officer and DirectorBrian KnaleyNA2025-01-31Resigned, continued to support via special projects until July 2025.
DirectorJohn BoltonNA2024-04-30Resigned.
DirectorKristi HummelNA2024-10-21Resigned.
DirectorLily Yan HughesNA2024-10-21Resigned.
DirectorElizabeth MoraNA2025-01-31Resigned.
DirectorDaniel HirschNA2025-01-31Resigned.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
NYSE American Listing Standards Non-ComplianceReceived a Notice of Noncompliance on April 29, 2025, for failing to maintain stockholders' equity of $2.0 million. Submitted a Compliance Plan, which was accepted on July 22, 2025, with a plan period until October 29, 2026.2025-04-29Indicates significant financial distress and potential delisting if compliance is not regained. Requires ongoing monitoring and strategic actions to improve financial health.
Board CompositionThe Board currently does not consist of a majority of independent directors, as Dario Barisoni ceased to be independent upon his appointment as Co-Chief Executive Officer. The Company is seeking to add additional independent directors.2025-10-01Potential impact on corporate governance best practices and compliance with NYSE American independence rules. Remedial action is being pursued.
Certificate of Incorporation AmendmentIncreased the number of authorized shares of stock to 950,000,000 (900,000,000 Common Stock and 50,000,000 Preferred Stock).2025-07-22Provides flexibility for future equity raises and acquisitions, but also enables significant potential dilution for existing shareholders.
Internal Control Over Financial ReportingIdentified material weaknesses in internal controls over financial reporting, specifically around accounting for complex financial instrument transactions and wire-transfer authorization.NAIncreases risk of financial misstatements and fraud. Remediation efforts are planned, including hiring personnel and adopting new policies, but success is not guaranteed.
Related Person Transactions PolicyThe Board adopted a written policy for identifying, reviewing, and overseeing related person transactions exceeding $120,000.NAAims to mitigate conflicts of interest and ensure fairness in dealings with related parties, though such transactions are still anticipated.

Legal Proceedings

  • CFGI, LLC obtained a default judgment of $86,826 in March 2025, which was paid in full by Silverback in September 2025.
  • FICTIV, Inc. obtained a default judgment of $197,899 on January 30, 2025, which was paid by the Company on September 23, 2025.
  • Centennial Tech Industrial Owner (Landlord) obtained a default judgment of $409,278 in April 2025, settled for $130,000 on October 14, 2025.
  • ficonTEC, Inc. obtained a default judgment of $394,274 in August 2025, settled on October 13, 2025.
  • Corporation for International Business obtained a default judgment of $30,379 in August 2025.
  • J.H. Darbie & Co., Inc. filed a claim on September 19, 2025, alleging breach of contract for advisory and finders fees, seeking damages and specific performance for warrants. The Company denies liability and intends to defend vigorously.

Related Party Transactions

  • Alessandro Zamboni (Executive Chairman and Co-CEO) is involved in multiple related party transactions, including the AZ Promissory Note ($900,000 loan to the Company), the TAG Promissory Note ($545,000 loan from The AvantGarde Group, owned by Mr. Zamboni), and the Orbit Acquisition (Orbit is wholly-owned by Mr. Zamboni indirectly through Vanguard).
  • The SYME Strategic Investment involves SYME, where Mr. Zamboni is the founder, current CEO, and a director. The proposed investment was negotiated and approved by independent board members and the Audit Committee.
  • The TCEI Acquisition (which expired) involved a $900,000 related-party promissory note to Mr. Zamboni, which was later amended to include a conversion feature.
  • A $1,350,000 receivable from Mr. Zamboni related to the expired TCEI Acquisition is reflected in prepaid expenses and other current assets.
  • Ron Nicol (former Executive Chairman) paid approximately $1.5 million in director and officer insurance premiums on behalf of the Company, which the Company is obligated to repay without interest.
  • Anzu Partners provided services to Legacy Nuburu and received a $500,000 payment and a warrant for 500,000 shares of Preferred Stock upon the Business Combination closing.
  • Certain Senior Convertible Notes and Junior Notes were held by related parties including Wilson-Garling 2023 Family Trust, David Seldin, Eunomia, LP (managed by Ron Nicol), and Curtis N Maas Revocable Trust.

Stakeholder Impact

  • Shareholders face significant dilution from ongoing and planned equity issuances (SEPA, public offering, convertible notes, acquisition consideration).
  • Existing shareholders' economic and voting interests will be diluted by the issuance of additional common stock.
  • Employees and consultants have experienced furloughs and resignations due to funding issues, impacting morale and operational stability.
  • Customers may face disruptions due to the Company's operational changes, including the discontinuation of manufacturing and pivot in laser business strategy.
  • Creditors involved in legal proceedings or settlements may receive common stock in lieu of cash, potentially impacting their recovery value.
  • The NYSE American listing status impacts investor confidence and liquidity for shareholders.

Next Steps

  • Continue to sell common stock to the Selling Stockholder under the SEPA to raise additional capital.
  • Negotiate and execute definitive agreements for the Tekne, Orbit, and Lyocon acquisitions.
  • Submit a new Golden Power application to the Italian government for the Tekne acquisition by December 31, 2025.
  • Hold a stockholders meeting by July 31, 2026, to seek approval for the issuance of Orbit Preferred Shares.
  • Execute a definitive joint venture agreement with Maddox Defense Incorporated by December 15, 2025.
  • Complete the Lyocon acquisition on or before December 31, 2025.
  • Pursue a lease for a replacement facility more appropriate for the new business strategy.
  • Recruit and retain additional management, human resources, accounting, finance, technical, engineering, and sales personnel.
  • Implement remediation measures for identified material weaknesses in internal control over financial reporting, including hiring additional qualified personnel and adopting written policies.
  • Seek to add additional independent directors to the Board to regain compliance with NYSE American rules.

Key Dates

DateDescription
2023-01-31Business Combination with Legacy Nuburu consummated; Company name changed to Nuburu, Inc.; Second anniversary of this date (Test Date) triggers Preferred Stock redemption obligation.
2023-11-13Company entered into Junior Note Purchase Agreements for $5.5 million in zero-interest promissory notes and Junior Note Warrants.
2024-02-22Stockholders approved proposals to authorize a reverse stock split of 1-for-30 to 1-for-75.
2024-05-01Company entered into a Pre-Funded Warrant Purchase Program with strategic investors for up to $15 million.
2024-07-23Company effected a 1-for-40 reverse stock split.
2024-08-06Company entered into a subordinated convertible note agreement with Esousa Group Holdings LLC for $673,000 (August 2024 Convertible Notes).
2024-08-19Company entered into an additional subordinated convertible note agreement with Esousa Group Holdings LLC for $687,315 (Additional August 2024 Convertible Notes).
2024-10-01Company entered into an unsecured promissory note with Liqueous LP for $1,053,824.
2024-12-16Lead Investor issued a notice of default and acceleration for Senior Convertible Notes.
2025-01-13Company entered into a letter agreement with S.F.E. Equity Investments SARL (SFE EI) for financing and the 'Transformation Plan'.
2025-01-14Company entered into a settlement and mutual release agreement with Liqueous LP.
2025-01-30FICTIV, Inc. obtained a default judgment of $197,899 against the Company.
2025-01-31Preferred Stock reclassified from mezzanine equity to a current liability due to redemption obligation.
2025-02-17Company entered into an amendment to the Liqueous Settlement Agreement, modifying pre-funded warrants.
2025-02-19Company entered into a commitment letter with Trumar Capital LLC to acquire interests in Tekne and Orbit.
2025-02-28Company entered into a share exchange agreement and master distribution agreement with HUMBL, Inc. (subsequently terminated).
2025-03-03Company issued unsecured convertible notes to Indigo Capital LP for $1,500,000 and in exchange for extinguishing August 2024 Convertible Notes.
2025-03-05Secured lenders concluded foreclosure sale of patent portfolio, extinguishing Junior and Senior Convertible Notes.
2025-03-14Company entered into a convertible facility with Supply@ME Capital Plc (SYME) to loan up to $5.15 million.
2025-03-31Company entered into a Joint Pursuit Agreement with Tekne (superseded by Tekne Letter).
2025-04-22Company issued unsecured convertible notes to Indigo Capital LP for $1,350,000 and in exchange for extinguishing an existing unsecured promissory note.
2025-04-29Company received a Notice of Noncompliance from NYSE Regulation.
2025-05-12Company entered into a Business Loan and Security Agreement with Agile Capital Funding, LLC for a $525,000 secured promissory note.
2025-05-13Company entered into Securities Purchase Agreements with 1800 Diagonal Lending LLC and Boot Capital LLC for convertible promissory notes.
2025-05-29Company submitted its Compliance Plan to NYSE Regulation.
2025-05-30Company entered into the Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD. for up to $100 million.
2025-06-03Company entered into transactions with Brick Lane Capital Management Limited for convertible notes in exchange for Preferred Stock and capital infusion.
2025-06-18Company entered into transactions with Bomore Opportunity Group Ltd for convertible notes in exchange for Preferred Stock and capital infusion.
2025-06-25Company entered into transactions with Torcross Capital LLC for a convertible note and planned exchange for Preferred Stock (rescinded in November 2025).
2025-06-30Company entered into a securities purchase agreement with YA II LN, LTD. (Yorkville) for a $1,250,000 debenture.
2025-07-09Company's stockholders approved issuances of Common Stock pursuant to the SEPA in excess of 19.99% and conversion of certain convertible notes.
2025-07-16Company issued a $150,000 unsecured convertible note to Indigo Capital LP.
2025-07-17Company and Silverback Capital Corporation agreed to settle outstanding claims for $5,662,479 in exchange for common stock.
2025-07-21Company issued a $172,700 convertible promissory note to 1800 Diagonal Lending LLC.
2025-07-22NYSE American accepted the Company's Compliance Plan, granting a plan period through October 29, 2026.
2025-07-24Registration statement for resale of up to 20 million SEPA shares declared effective by SEC.
2025-07-30State court approved the Silverback Claims Settlement.
2025-07-31Trumar Agreement expired as certain conditions were not satisfied.
2025-08-18Company issued a $225,000 unsecured convertible note to Indigo Capital LP.
2025-08-27Company executed a commitment letter (August Letter) with Tekne shareholders, modifying acquisition terms (superseded by November Tekne Letter).
2025-08-31ficonTEC, Inc. obtained a default judgment of $394,274 against the Company.
2025-09-02Company issued a $125,000 unsecured convertible note to Brick Lane Capital Management Limited.
2025-09-16Company consummated a best efforts public offering, raising $10.7 million net proceeds.
2025-09-19J.H. Darbie & Co., Inc. filed a lawsuit against the Company alleging breach of contract.
2025-09-23Registration statement for resale of up to 30 million additional SEPA shares declared effective by SEC.
2025-10-06Signing of the binding letter of intent (Orbit LOI) between the Company and Alessandro Zamboni for Orbit acquisition.
2025-10-13Company settled default judgment with ficonTEC, Inc.
2025-10-14Company settled default judgment with Centennial Tech Industrial Owner (Landlord) for $130,000.
2025-10-22Company entered into a non-binding Strategic Framework Agreement with Maddox Defense Incorporated to establish a joint venture.
2025-10-31Company entered into the Sale, Purchase and Investment Agreement (Orbit Agreement) for the acquisition of Orbit S.r.l.
2025-11-13Company, Tekne, and Tekne shareholders executed a letter of intent (Tekne Letter) replacing the August Letter.
2025-11-14Silverback program concluded.
2025-11-28Company entered into a binding term sheet to acquire Lyocon S.r.l.
2025-12-08Last quoted sale price for common stock on NYSE American was $0.2262 per share; Company filed a motion to dismiss J.H. Darbie & Co. lawsuit.
2025-12-12Date of this S-1 filing.
2025-12-15Target date for executing a definitive joint venture agreement with Maddox Defense Incorporated.
2025-12-31Target closing date for Lyocon acquisition; Target date for submitting new Golden Power application for Tekne; Target closing date for Orbit Acquisition (final tranche by Dec 31, 2026).
2026-03-16End of six-month restriction on Variable Rate Transactions from the Public Offering.
2026-07-31Deadline for holding a stockholders meeting to seek approval of Orbit Preferred Shares issuance.
2026-08-31Expiration date of letters of credit for Tekne acquisition, with collateral release 30 days later.
2026-10-29Compliance deadline for regaining NYSE American listing standards.
2028-10-07Final tranche closing date for Orbit Equity Infusion.

Recommendation

strong sell

NUBURU faces severe financial distress, evidenced by recurring significant net losses, a substantial accumulated deficit, and a 'going concern' qualification from its auditors. The NYSE American has issued a non-compliance notice, indicating a risk of delisting. The company's core blue laser patent portfolio was foreclosed upon, fundamentally altering its original business model. While NUBURU is attempting a strategic pivot through acquisitions in defense-tech, security, and fintech, these initiatives are high-risk, subject to numerous contingencies (regulatory, stockholder approvals), and require substantial capital that the company is struggling to secure. The recent fraudulent wire transfer highlights internal control weaknesses. The ongoing and potential future dilution from various equity raises, coupled with the company's inability to generate meaningful revenue and its precarious liquidity position, makes the stock a high-risk, speculative investment with a strong likelihood of further value erosion. Seasoned investors would likely view the current situation as unsustainable without a clear path to profitability and operational stability.

Keywords

NUBURU, SEC Filing, S-1, Standby Equity Purchase Agreement, SEPA, Common Stock, Dilution, Capital Raise, Acquisitions, Defense Technology, Fintech, Inventory Monetization, Operational Resilience, Laser Technology, NYSE American, Non-compliance, Going Concern, Convertible Notes, Warrants, Intellectual Property, Fraud, Financial Reporting, Risk Factors

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.